Pfizer Settles Off-Label Promotion Charges Pfizer has agreed to pay $55 million plus interest to settle charges that Wyeth (acquired by Pfizer in October 2009) improperly promoted the drug Protonix. More...
FDA Issues Draft Guidance on Electronic Submissions FDA has issued a draft guidance relating to electronic submissions, which is one in a series of documents intended to assist sponsors and applicants making certain regulatory submissions to FDA in electronic format. More...
Get the Latest Updates on Twitter We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
The Nexera MP UHPLC for LC/MS analysis in drug detection processes
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes. Read more
Do you think more regulatory attention is needed in the area of tablet splitting?
Yes
62%
No
38%
This week we would like to know...
What area of the pharmaceutical industry do you think will experience the most change in 2013?
